Identification of miR-16-5p and miR-155-5p microRNAs differentially expressed in circulating leukocytes of pregnant women with polycystic ovary syndrome and gestational diabetes

References

• Hu Y, Wen S, Yuan D, et al. The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2018;34:370–377.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Tian F, Li H, et al. Profiling maternal plasma microRNA expression in early pregnancy to predict gestational diabetes mellitus. Int J Gynaecol Obstet. 2015;130:49–53.
   PubMed Web of Science ®Google Scholar
• Foroozanfard F, Asemi Z, Bazarganipour F, et al. Comparing pregnancy, childbirth, and neonatal outcomes in women with different phenotypes of polycystic ovary syndrome and healthy women: a prospective cohort study. Gynecol Endocrinol. 2020;36:61–65.
   PubMed Web of Science ®Google Scholar
• Kyriazi AA, Papiris E, Kitsos Kalyvianakis K, et al. Dual effects of non-coding RNAs (ncRNAs) in cancer stem cell biology. IJMS. 2020;21:6658.
   Google Scholar
• Cao YL, Jia YJ, Xing BH, et al. Plasma microRNA-16-5p, -17-5p and -20a-5p: novel diagnostic biomarkers for gestational diabetes mellitus. J Obstet Gynaecol Res. 2017;43:974–981.
   PubMed Web of Science ®Google Scholar
• Martínez-Ibarra A, Martínez-Razo LD, Vázquez-Martínez ER, et al. Unhealthy levels of phthalates and bisphenol A in Mexican pregnant women with gestational diabetes and its association to altered expression of miRNAs involved with metabolic disease. IJMS. 2019;20:3343.
   Google Scholar
• Pheiffer C, Dias S, Rheeder P, et al. Decreased expression of circulating miR-20a-5p in south African women with gestational diabetes mellitus. Mol Diagn Ther. 2018;22:345–352.
   PubMed Web of Science ®Google Scholar
• Polina ER, Oliveira FM, Sbruzzi RC, et al. Gene polymorphism and plasma levels of miR-155 in diabetic retinopathy. Endocr Connect. 2019;8:1591–1599.
   PubMed Web of Science ®Google Scholar
• Wander PL, Boyko EJ, Hevner K, et al. Circulating early-and mid-pregnancy microRNAs and risk of gestational diabetes. Diabetes Res Clin Pract. 2017;132:1–9.
   PubMed Web of Science ®Google Scholar
• Hocaoglu M, Demirer S, Senturk H, et al. Differential expression of candidate circulating microRNAs in maternal blood leukocytes of the patients with preeclampsia and gestational diabetes mellitus. Pregnancy Hypertens. 2019;17:5–11.
   PubMed Web of Science ®Google Scholar
• , Metzger BE, Gabbe SG, Persson B, International Association of Diabetes and Pregnancy Study Groups Consensus Panel, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–682.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term [20] health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
   Web of Science ®Google Scholar
• Keyif B, Goksever Celik H, Karamustafaoglu Balci B, et al. Serum betatrophin levels are significantly increased in obese patients compared to lean patients regardless to the presence of PCOS. Gynecol Endocrinol. 2020;4:1–4.
   Google Scholar
• Faul F, Erdfelder E, Lang AG, et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–191.
   PubMed Web of Science ®Google Scholar
• Ameling S, Kacprowski T, Chilukoti RK, et al. Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study. BMC Med Genomics. 2015;8:61.
   PubMed Web of Science ®Google Scholar
• Zhao C, Liu X, Shi Z, et al. Role of serum miRNAs in the prediction of ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients. Cell Physiol Biochem. 2015;35:1086–1094.
   PubMedGoogle Scholar
• Fu X, He Y, Wang X, et al. MicroRNA-16 promotes ovarian granulosa cell proliferation and suppresses apoptosis through targeting PDCD4 in polycystic ovarian syndrome. Cell Physiol Biochem. 2018;48:670–682.
   PubMedGoogle Scholar
• Chatterjee A, Chattopadhyay D, Chakrabarti G. MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis. Cell Signal. 2015;27:189–203.
   PubMed Web of Science ®Google Scholar
• Cirillo F, Catellani C, Lazzeroni P, et al. MiRNAs regulating insulin sensitivity are dysregulated in Polycystic Ovary Syndrome (PCOS) ovaries and are associated with markers of inflammation and insulin sensitivity. Front Endocrinol (Lausanne). 2019;10:879.
   PubMed Web of Science ®Google Scholar
• Arancio W, Calogero Amato M, Magliozzo M, et al. Serum miRNAs in women affected by hyperandrogenic polycystic ovary syndrome: the potential role of miR-155 as a biomarker for monitoring the estroprogestinic treatment. Gynecol Endocrinol. 2018;34:704–708.
   PubMed Web of Science ®Google Scholar
• Murri M, Insenser M, Fernández-Durán E, et al. Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression. J Clin Endocrinol Metab. 2013;98:E1835–E1844.
   PubMed Web of Science ®Google Scholar
• Corral-Fernandez NE, Salgado-Bustamante M, Martinez-Leija ME, et al. Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2013;121:347–353.
   PubMed Web of Science ®Google Scholar
• García-Díaz DF, Pizarro C, Camacho-Guillén P, et al. Expression of miR-155, miR-146a, and miR-326 in T1D patients from Chile: relationship with autoimmunity and inflammatory markers. Arch Endocrinol Metab. 2018;62:34–40.
   PubMed Web of Science ®Google Scholar
• Khamaneh AM, Alipour MR, Hesari FS, et al. A signature of microRNA-155 in the pathogenesis of diabetic complications. J Physiol Biochem. 2015;71:301–309.
   PubMed Web of Science ®Google Scholar
• Stoikou M, Grimolizzi F, Giaglis S, et al. Gestational Diabetes Mellitus is associated with altered neutrophil activity. Front Immunol. 2017;8:702.
   PubMed Web of Science ®Google Scholar
• Piltonen TT, Giacobini P, Edvinsson A, et al. Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term. Fertil Steril. 2019;111:588–596.
   PubMed Web of Science ®Google Scholar